Related references
Note: Only part of the references are listed.Histone Deacetylase Inhibitors Influence Chemotherapy Transport by Modulating Expression and Trafficking of a Common Polymorphic Variant of the ABCG2 Efflux Transporter
Agnes Basseville et al.
CANCER RESEARCH (2012)
Requirements for Efficient Correction of ΔF508 CFTR Revealed by Analyses of Evolved Sequences
Juan L. Mendoza et al.
CELL (2012)
Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ΔF508 CFTR Folding and Function
Wael M. Rabeh et al.
CELL (2012)
ABCG2 null alleles define the Jr(a-) blood group phenotype
Teresa Zelinski et al.
NATURE GENETICS (2012)
Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior
Carole Saison et al.
NATURE GENETICS (2012)
Decreased extra-renal urate excretion is a common cause of hyperuricemia
Kimiyoshi Ichida et al.
NATURE COMMUNICATIONS (2012)
ABCG transporters and disease
Owen M. Woodward et al.
FEBS JOURNAL (2011)
4-Phenylbutyrate Stimulates Hsp70 Expression through the Elp2 Component of Elongator and STAT-3 in Cystic Fibrosis Epithelial Cells
Laurence Suaud et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Probing Conformational Rescue Induced by a Chemical Corrector of F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutant
Wilson Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Ubiquitin-Mediated Proteasomal Degradation of ABC Transporters: a New Aspect of Genetic Polymorphisms and Clinical Impacts
Hiroshi Nakagawa et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
BCRP/ABCG2 confers anticancer drug resistance without covalent dimerization
Junichi Shigeta et al.
CANCER SCIENCE (2010)
Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)
Zhanglin Ni et al.
CURRENT DRUG METABOLISM (2010)
The Cystic Fibrosis-causing Mutation ΔF508 Affects Multiple Steps in Cystic Fibrosis Transmembrane Conductance Regulator Biogenesis
Patrick H. Thibodeau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A 'complexity' of urate transporters
Alan F. Wright et al.
KIDNEY INTERNATIONAL (2010)
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis
Darren M. Hutt et al.
NATURE CHEMICAL BIOLOGY (2010)
The Primary Folding Defect and Rescue of ΔF508 CFTR Emerge during Translation of the Mutant Domain
Hanneke Hoelen et al.
PLOS ONE (2010)
Quality control of human ABCG2 protein in the endoplasmic reticulum: Ubliquitination and proteasomal degradation
Kanako Wakabayashi-Nakao et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Purification and structural analyses of ABCG2
Christopher A. McDevitt et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Hyperuricemia and Risk of Stroke: A Systematic Review and Meta-Analysis
Seo Young Kim et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Correctors Enhance Maturation of ΔF508 CFTR by Promoting Interactions between the Two Halves of the Molecule
Tip W. Loo et al.
BIOCHEMISTRY (2009)
The role of hyperuricemia and gout in kidney and cardiovascular disease
N. L. EDWARDS
CLEVELAND CLINIC JOURNAL OF MEDICINE (2009)
Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes?
Richard J. Johnson et al.
ENDOCRINE REVIEWS (2009)
Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure
Corinna Bergamini et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Lessons from comparative physiology: could uric acid represent a physiologic alarm signal gone awry in western society?
Richard J. Johnson et al.
JOURNAL OF COMPARATIVE PHYSIOLOGY B-BIOCHEMICAL SYSTEMS AND ENVIRONMENTAL PHYSIOLOGY (2009)
Major SNP (Q141K) Variant of Human ABC Transporter ABCG2 Undergoes Lysosomal and Proteasomal Degradations
Tomoka Furukawa et al.
PHARMACEUTICAL RESEARCH (2009)
Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout
Owen M. Woodward et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?
Angelo L. Gaffo et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Localization Studies of Rare Missense Mutations in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Facilitate Interpretation of Genotype-Phenotype Relationships
Kristina V. Krasnov et al.
HUMAN MUTATION (2008)
Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function
Adrian W. R. Serohijos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Adapting proteostasis for disease intervention
William E. Balch et al.
SCIENCE (2008)
Correctors promote maturation of cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by binding to the protein
Ying Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Knockdown of NHERF1 enhances degradation of temperature rescued Delta 508 CFTR from the cell surface of human airway cells
Sang-Ho Kwon et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2007)
Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms
Monica Roxo-Rosa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Rescue of ΔF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules
F Van Goor et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
New insights into cystic fibrosis: molecular switches that regulate CFTR
William B. Guggino et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Role of Cys-603 in dimer/oligomer formation of the breast cancer resistance protein BCRP/ABCG2
K Kage et al.
CANCER SCIENCE (2005)
Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2
U Henriksen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Small-molecule correctors of defective ΔF508-CFTR cellular processing identified by high-throughput screening
N Pedemonte et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Single nucleotide polymorphisms modify the transporter activity of ABCG2
K Morisaki et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Rescue of Delta F508 and other misprocessed CFTR mutants by a novel quinazoline compound
Tip W. Loo et al.
MOLECULAR PHARMACEUTICS (2005)
Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2
S Mizuarai et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Functional analysis of SNPs variants of BCRP/ABCG2
C Kondo et al.
PHARMACEUTICAL RESEARCH (2004)
Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2
T Litman et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2002)
Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization
K Kage et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells
C Özvegy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Share Paper
